Compared to the homozygous genotype ‘AA’ in the AXIN2 rs3923087, the heterozygotes ‘AG’ showed about 2.7 fold decrease risk of developing cancer (OR, 0.373; CI, 0.193–0.720; p = 0.00298). This evidence concerns the gene AXIN2 and cancer.